TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from HitIQ Limited ( (AU:HIQ) ).
HITIQ Limited has announced the retail distribution of its PROTEQT™ concussion management system through rebel, Australia’s leading sporting goods retailer. This strategic move marks HITIQ’s entry into the consumer retail market, leveraging rebel’s extensive retail network and brand recognition. The collaboration with Shock Doctor has facilitated this transition, positioning PROTEQT™ for availability ahead of the 2026 sports season. This initiative aims to capture the growing demand for safety products in contact sports, driven by increased safety awareness and regulatory focus on athlete safety.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
More about HitIQ Limited
HITIQ Limited operates in the sports technology industry, focusing on concussion management systems. Their primary product, PROTEQT™, is designed to enhance athlete safety and is targeted at both community and competitive sports participants. The company is expanding its market focus from elite sports to mainstream consumer retail channels.
Average Trading Volume: 612,595
Technical Sentiment Signal: Sell
Current Market Cap: A$11.7M
Learn more about HIQ stock on TipRanks’ Stock Analysis page.